| Saham Orang Dalam | 1,234,255 shares |
Skor Sentimen Orang Dalam
Skor Sentimen Orang Dalam mengidentifikasi perusahaan yang dibeli oleh orang dalam korporat.
Ini adalah hasil dari model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi internal tertinggi. Model penilaian ini menggunakan kombinasi dari jumlah bersih orang dalam yang membeli dalam 90 hari sebelumnya, total saham yang dibeli sebagai persentase dari jumlah saham yang beredar, dan total saham yang dimiliki oleh orang dalam. Angka tersebut berkisar dari 0 hingga 100, dengan angka yang lebih tinggi menunjukkan tingkat akumulasi yang lebih tinggi dibandingkan dengan perusahaan sejenis, dan 50 adalah rata-rata.
Frekuensi Pembaruan: Setiap Hari
Skor Sentimen Petugas
Skor Sentimen Pejabat menemukan perusahaan yang dibeli oleh Pejabat Korporat.
Menurut definisi, Pejabat Korporasi adalah Orang Dalam Korporasi, tetapi tidak seperti beberapa Orang Dalam lainnya (Pemegang Saham 10% dan Anggota Dewan), Pejabat bekerja untuk perusahaan setiap hari, dan mereka menggunakan uang mereka sendiri saat bertransaksi . (Pemegang Saham 10% dan Anggota Dewan seringkali adalah manajer dana yang mengelola uang orang lain.) Dengan demikian, transaksi orang dalam yang dilakukan oleh Pejabat jauh lebih signifikan dan harus ditangani dengan tepat.
Seperti Skor Sentimen Internal, Skor Sentimen Pejabat adalah hasil dari model kuantitatif multi-faktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi pejabat tertinggi.
Frekuensi Pembaruan: Setiap Hari
Metrik Utama Orang Dalam
Kartu ini menunjukkan peringkat perusahaan berdasarkan berbagai metrik internal. Peringkat persentil menunjukkan bagaimana perusahaan ini dibandingkan dengan perusahaan lain di pasar AS. Peringkat yang lebih tinggi menunjukkan situasi yang lebih baik.
Sebagai contoh, secara umum diterima bahwa pembelian oleh orang dalam perusahaan adalah indikator positif, sehingga perusahaan dengan lebih banyak pembelian oleh orang dalam akan mendapat peringkat lebih tinggi daripada perusahaan dengan lebih sedikit pembelian oleh orang dalam (atau bahkan penjualan oleh orang dalam).
Jumlah Bersih Pembelian oleh Orang Dalam (Peringkat)
N/A
Jumlah Bersih Pembelian oleh Orang Dalam adalah total jumlah orang dalam yang membeli dikurangi total jumlah orang dalam yang menjual dalam 90 hari terakhir. Peringkat persentil ditunjukkan di sini (kisaran dari 0 hingga 100%).
Persentase Saham yang Dibeli oleh Orang Dalam (Peringkat)
N/A
Persentase Saham yang Dibeli oleh Orang Dalam adalah total jumlah saham yang dibeli oleh orang dalam dikurangi total jumlah saham yang dijual oleh orang dalam dalam 90 hari terakhir, dibagi dengan total jumlah saham yang beredar dan dikalikan dengan 100.
Grafik Perdagangan Orang Dalam
Grafik berikut menunjukkan Harpoon Therapeutics, Inc. transaksi orang dalam. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Secara umum, melakukan transaksi di perusahaan mereka berdasarkan informasi material yang belum dipublikasikan adalah ilegal bagi orang dalam. Ini tidak berarti bahwa mereka dilarang melakukan transaksi apa pun di perusahaan mereka sendiri. Namun, mereka wajib melaporkan semua transaksi kepada SEC melalui Formulir 4.
Daftar Orang Dalam dan Metrik Profitabilitas
Tabel ini menampilkan daftar orang dalam yang diketahui, dan dibuat secara otomatis dari pengajuan yang diungkapkan kepada SEC. Selain nama, jabatan terbaru, dan sebutan direktur, pejabat, atau pemilik 10%, kami memberikan kepemilikan terbaru yang diungkapkan. Selain itu, jika memungkinkan, kami memberikan kinerja perdagangan historis untuk orang dalam tersebut. Kinerja perdagangan historis adalah rata-rata tertimbang dari kinerja transaksi pembelian pasar terbuka aktual yang dilakukan oleh orang dalam tersebut. Untuk informasi lebih lanjut tentang bagaimana ini dihitung, tonton webinar YouTube ini.
See our leaderboard of most profitable insider traders.
| Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
|---|
Report errors via our new Insider Auditing Tool
Rekam Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di HARP / Harpoon Therapeutics, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Rekam Jejak Penjualan Orang Dalam - Analisis Kerugian Jangka Pendek
Dalam bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan dalam pasar terbuka yang tidak direncanakan oleh orang dalam yang dilakukan di HARP / Harpoon Therapeutics, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Riwayat Transaksi
Klik ikon tautan untuk melihat riwayat transaksi lengkap. Transaksi yang dilaporkan sebagai bagian dari rencana perdagangan otomatis 10b5-1 akan memiliki tanda X di kolom yang bertanda 10b-5.
| Berkas Tanggal |
Perdagangan Tanggal |
Formulir | Orang Dalam | Ticker | Judul Keamanan | Kode | Langsung | Latihan Harga |
Satuan Harga |
Unit Diubah |
Nilai Diubah (1 ribu) |
Sisa Pilihan |
Sisa Saham |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-11 | 2024-03-11 | 4 | New Leaf Biopharma Opportunities II, L.P. | HARP | 8.000% Series A Redeemable Preferred Stock | D | -10,000 | 0 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | New Leaf Biopharma Opportunities II, L.P. | HARP | Common Stock | I | -395,783 | 0 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | New Leaf Biopharma Opportunities II, L.P. | HARP | Common Stock | D | -1,463,386 | 0 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | Walker Luke Nathaniel | HARP | Common Stock | D | -135,000 | 0 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | SILVERNAIL LAUREN P | HARP | Common Stock | D | -5,000 | 0 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | HUNT RONALD | HARP | 8.000% Series A Redeemable Preferred Stock | I | -10,000 | 0 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | HUNT RONALD | HARP | Common Stock | I | -395,783 | 0 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | HUNT RONALD | HARP | Common Stock | I | -1,463,386 | 0 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | HUNT RONALD | HARP | Common Stock | D | -13,224 | 0 | ||||||
| 2024-03-11 | 2024-03-08 | 4 | HUNT RONALD | HARP | Common Stock | D | 424 | 13,224 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | Myers Scott Dunseth | HARP | Common Stock | D | -22,665 | 0 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | Chin Mark | HARP | Common Stock | D | -13,224 | 0 | ||||||
| 2024-03-11 | 2024-03-08 | 4 | Chin Mark | HARP | Common Stock | D | 424 | 13,224 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | DRACHMAN JONATHAN G | HARP | Common Stock | D | -5,415 | 0 | ||||||
| 2024-03-11 | 2024-03-08 | 4 | DRACHMAN JONATHAN G | HARP | Common Stock | D | 415 | 5,415 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | Robbins Andrew R | HARP | Common Stock | D | -5,000 | 0 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | BAILES JOSEPH S | HARP | Common Stock | D | -5,000 | 0 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | EASTLAND JULIA MARIE | HARP | Common Stock | D | -269,381 | 0 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | EASTLAND JULIA MARIE | HARP | Common Stock | D | 31,250 | 269,381 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | Lanza Frank J | HARP | Common Stock | D | -18,734 | 0 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | Merck & Co., Inc. | HARP | Common Stock, par value $0.0001 | I | 23.0000 | 21,397,205 | 492,136 | 1,000 | ||||
| 2024-01-17 | 3 | Merck & Co., Inc. See Footnotes | HARP | Common Stock, par value $0.0001 | I | 0 | ||||||||
| 2024-01-09 | 2024-01-07 | 4 | Lanza Frank J | HARP | Common Stock | D | 15,000 | 18,362 | ||||||
| 2024-01-09 | 2024-01-07 | 4 | EASTLAND JULIA MARIE | HARP | Common Stock | D | 178,500 | 232,003 | ||||||
| 2024-01-09 | 2024-01-07 | 4 | Walker Luke Nathaniel | HARP | Common Stock | D | 115,000 | 135,000 | ||||||
| 2024-01-03 | 2024-01-01 | 4 | Chin Mark | HARP | Common Stock | D | 1,072 | 12,801 | ||||||
| 2024-01-03 | 2024-01-01 | 4 | HUNT RONALD | HARP | Common Stock | D | 1,072 | 12,801 | ||||||
| 2024-01-03 | 2024-01-01 | 4 | Myers Scott Dunseth | HARP | Common Stock | D | 2,048 | 22,666 | ||||||
| 2023-11-28 | 2023-11-26 | 4 | Walker Luke Nathaniel | HARP | Common Stock | D | 20,000 | 20,000 | ||||||
| 2023-11-28 | 2023-11-26 | 4 | Lanza Frank J | HARP | Common Stock | D | 2,000 | 3,362 | ||||||
| 2023-11-28 | 2023-11-26 | 4 | EASTLAND JULIA MARIE | HARP | Common Stock | D | 50,000 | 53,503 | ||||||
| 2023-11-28 | 2023-11-27 | 4 | SILVERNAIL LAUREN P | HARP | Common Stock | D | 5,000 | 5,000 | ||||||
| 2023-11-28 | 2023-11-27 | 4 | Robbins Andrew R | HARP | Common Stock | D | 5,000 | 5,000 | ||||||
| 2023-11-28 | 2023-11-27 | 4 | Myers Scott Dunseth | HARP | Common Stock | D | 5,000 | 20,618 | ||||||
| 2023-11-28 | 2023-11-27 | 4 | HUNT RONALD | HARP | Common Stock | D | 5,000 | 11,729 | ||||||
| 2023-11-28 | 2023-11-27 | 4 | Chin Mark | HARP | Common Stock | D | 5,000 | 11,729 | ||||||
| 2023-11-28 | 2023-11-27 | 4 | DRACHMAN JONATHAN G | HARP | Common Stock | D | 5,000 | 5,000 | ||||||
| 2023-11-28 | 2023-11-27 | 4 | BAILES JOSEPH S | HARP | Common Stock | D | 5,000 | 5,000 | ||||||
| 2023-10-27 | 2023-10-25 | 4 | New Leaf Biopharma Opportunities II, L.P. | HARP | Common Stock | I | 171,500 | 395,783 | ||||||
| 2023-10-27 | 2023-10-25 | 4 | New Leaf Biopharma Opportunities II, L.P. | HARP | Common Stock | D | 1,372,000 | 1,463,386 | ||||||
| 2023-10-27 | 2023-10-25 | 4 | HUNT RONALD | HARP | Common Stock | I | 171,500 | 395,783 | ||||||
| 2023-10-27 | 2023-10-25 | 4 | HUNT RONALD | HARP | Common Stock | I | 1,372,000 | 1,463,386 | ||||||
| 2023-10-02 | 2023-10-01 | 4 | Myers Scott Dunseth | HARP | Common Stock | D | 5,797 | 15,618 | ||||||
| 2023-10-02 | 2023-10-01 | 4 | HUNT RONALD | HARP | Common Stock | D | 3,035 | 6,729 | ||||||
| 2023-10-02 | 2023-10-01 | 4 | Chin Mark | HARP | Common Stock | D | 3,035 | 6,729 | ||||||
| 2023-07-06 | 2023-07-01 | 4 | Myers Scott Dunseth | HARP | Common Stock | D | 35,634 | 98,215 | ||||||
| 2023-07-06 | 2023-07-01 | 4 | Chin Mark | HARP | Common Stock | D | 18,656 | 36,941 | ||||||
| 2023-07-06 | 2023-07-01 | 4 | HUNT RONALD | HARP | Common Stock | D | 18,656 | 36,941 | ||||||
| 2023-04-04 | 2023-04-01 | 4 | Colowick Alan | HARP | Common Stock | D | 16,456 | 16,456 | ||||||
| 2023-04-04 | 2023-04-01 | 4 | Myers Scott Dunseth | HARP | Common Stock | D | 34,925 | 62,581 | ||||||
| 2023-04-04 | 2023-04-01 | 4 | HUNT RONALD | HARP | Common Stock | D | 18,285 | 18,285 | ||||||
| 2023-04-04 | 2023-04-01 | 4 | Chin Mark | HARP | Common Stock | D | 18,285 | 18,285 | ||||||
| 2023-04-04 | 2023-04-01 | 4 | Viney Joanne L. | HARP | Common Stock | D | 21,028 | 21,028 | ||||||
| 2023-03-27 | 3 | Lathi Vijay K See footnotes | HARP | Common Stock | I | 2,242,839 | ||||||||
| 2023-03-27 | 3 | Lathi Vijay K | HARP | Common Stock | D | 913,860 | ||||||||
| 2023-03-27 | 3 | Lathi Vijay K | HARP | 8.000% Series A Redeemable Preferred Stock | D | 10,000 | ||||||||
| 2023-03-27 | 2023-03-23 | 4 | HUNT RONALD | HARP | 8.000% Series A Redeemable Preferred Stock | I | 1,000.0000 | 10,000 | 10,000 | 10,000 | ||||
| 2022-10-04 | 3 | Walker Luke Nathaniel | HARP | No securities are beneficially owned | D | 0 | ||||||||
| 2022-09-19 | 3 | Lanza Frank J | HARP | Common Stock | D | 6,540 | ||||||||
| 2022-09-19 | 3 | SILVERNAIL LAUREN P | HARP | No securities are beneficially owned | D | 0 | ||||||||
| 2022-02-01 | 2022-01-28 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 5.03 | 135,000 | 135,000 | |||||
| 2022-02-01 | 2022-01-28 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 5.03 | 155,000 | 155,000 | |||||
| 2022-02-01 | 2022-01-28 | 4 | Erbez Georgia | HARP | Employee Stock Option (right to buy) | D | 5.03 | 115,000 | 115,000 | |||||
| 2021-11-15 | 2021-11-11 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 7.73 | 135,000 | 135,000 | |||||
| 2021-11-15 | 2021-11-11 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 7.73 | 155,000 | 155,000 | |||||
| 2021-11-15 | 2021-11-11 | 4 | Erbez Georgia | HARP | Employee Stock Option (right to buy) | D | 7.73 | 115,000 | 115,000 | |||||
| 2021-11-09 | 2021-11-08 | 4 | EASTLAND JULIA MARIE | HARP | Stock Option (Right to Buy) | D | 6.85 | 350,000 | 350,000 | |||||
| 2021-10-26 | 2021-10-25 | 4 | Myers Scott Dunseth | HARP | Director Stock Option (Right to Buy) | D | 6.31 | 10,167 | 10,167 | |||||
| 2021-09-22 | 2021-09-22 | 4 | Erbez Georgia By IRA | HARP | Common Stock | I | 8.1000 | 10,300 | 83 | 19,215 | ||||
| 2021-08-12 | 2021-01-11 | 4 | New Leaf Ventures III, L.P. | HARP | Common Stock | I | 17.0000 | 235,294 | 4,000 | 913,860 | ||||
| 2021-08-12 | 2021-01-11 | 4 | HUNT RONALD | HARP | Common Stock | I | 17.0000 | 235,294 | 4,000 | 913,860 | ||||
| 2021-07-06 | 2021-07-01 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 0.60 | -10,000 | 21,002 | |||||
| 2021-07-06 | 2021-07-01 | 4 | Wesche Holger | HARP | Common Stock | D | 14.0000 | -10,000 | -140 | 52,852 | ||||
| 2021-07-06 | 2021-07-01 | 4 | Wesche Holger | HARP | Common Stock | D | 0.6000 | 10,000 | 6 | 62,852 | ||||
| 2021-06-02 | 2021-06-02 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20.5000 | -25,118 | -515 | 6,328,095 | ||||
| 2021-06-02 | 2021-06-01 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20.4400 | -18,491 | -378 | 6,353,213 | ||||
| 2021-06-02 | 2021-05-28 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 22.6000 | -100 | -2 | 6,371,704 | ||||
| 2021-06-02 | 2021-05-28 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 21.9200 | -3,100 | -68 | 6,371,804 | ||||
| 2021-06-02 | 2021-05-28 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20.8800 | -10,685 | -223 | 6,374,904 | ||||
| 2021-05-27 | 2021-05-27 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20.2600 | -13,961 | -283 | 6,385,589 | ||||
| 2021-05-27 | 2021-05-26 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20.0400 | -3,198 | -64 | 6,399,550 | ||||
| 2021-05-24 | 2021-05-24 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20.1200 | -5,000 | -101 | 6,402,748 | ||||
| 2021-05-24 | 2021-05-21 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20.2100 | -10,907 | -220 | 6,407,748 | ||||
| 2021-05-20 | 2021-05-20 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20.3400 | -11,713 | -238 | 6,418,655 | ||||
| 2021-05-20 | 2021-05-19 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20.3900 | -17,833 | -364 | 6,430,368 | ||||
| 2021-05-20 | 2021-05-18 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20.6700 | -18,402 | -380 | 6,448,201 | ||||
| 2021-05-17 | 2021-05-17 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20.0700 | -4,666 | -94 | 6,466,603 | ||||
| 2021-05-17 | 2021-05-14 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20.0400 | -6,900 | -138 | 6,471,269 | ||||
| 2021-05-17 | 2021-05-13 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20.0600 | -4,855 | -97 | 6,478,169 | ||||
| 2021-05-14 | 2021-05-04 | 4/A | Viney Joanne L. | HARP | Director Stock Option (Right to Buy) | D | 23.20 | 2,571 | 2,571 | |||||
| 2021-05-14 | 2021-05-04 | 4/A | Viney Joanne L. | HARP | Director Stock Option (Right to Buy) | D | 23.20 | 10,167 | 10,167 | |||||
| 2021-05-14 | 2021-05-04 | 4/A | BAILES JOSEPH S | HARP | Director Stock Option (Right to Buy) | D | 23.20 | 10,167 | 10,167 | |||||
| 2021-05-14 | 2021-05-04 | 4/A | Robbins Andrew R | HARP | Director Stock Option (Right to Buy) | D | 23.20 | 10,167 | 10,167 | |||||
| 2021-05-14 | 2021-05-04 | 4/A | Myers Scott Dunseth | HARP | Director Stock Option (Right to Buy) | D | 23.20 | 10,167 | 10,167 | |||||
| 2021-05-14 | 2021-05-04 | 4/A | EASTLAND JULIA MARIE | HARP | Director Stock Option (Right to Buy) | D | 23.20 | 10,167 | 10,167 | |||||
| 2021-05-14 | 2021-05-04 | 4/A | HUNT RONALD | HARP | Director Stock Option (Right to Buy) | D | 23.20 | 4,658 | 4,658 | |||||
| 2021-05-14 | 2021-05-04 | 4/A | HUNT RONALD | HARP | Director Stock Option (Right to Buy) | D | 23.20 | 10,167 | 10,167 | |||||
| 2021-05-14 | 2021-05-04 | 4/A | DRACHMAN JONATHAN G | HARP | Director Stock Option (Right to Buy) | D | 23.20 | 10,167 | 10,167 | |||||
| 2021-05-14 | 2021-05-04 | 4/A | Chin Mark | HARP | Director Stock Option (Right to Buy) | D | 23.20 | 2,438 | 2,438 | |||||
| 2021-05-14 | 2021-05-04 | 4/A | Chin Mark | HARP | Director Stock Option (Right to Buy) | D | 23.20 | 10,167 | 10,167 | |||||
| 2021-05-12 | 2021-05-12 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20.5300 | -29,684 | -609 | 6,483,024 | ||||
| 2021-05-12 | 2021-05-11 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 21.5100 | -7,672 | -165 | 6,512,708 | ||||
| 2021-05-12 | 2021-05-11 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20.9600 | -13,773 | -289 | 6,520,380 | ||||
| 2021-05-12 | 2021-05-10 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 22.4600 | -411 | -9 | 6,534,153 | ||||
| 2021-05-12 | 2021-05-10 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 21.7800 | -16,722 | -364 | 6,534,564 | ||||
| 2021-05-07 | 2021-05-04 | 4 | Colowick Alan | HARP | Director Stock Option (Right to Buy) | D | 22.50 | 10,167 | 10,167 | |||||
| 2021-05-07 | 2021-05-04 | 4 | Viney Joanne L. | HARP | Director Stock Option (Right to Buy) | D | 22.50 | 2,653 | 2,653 | |||||
| 2021-05-07 | 2021-05-04 | 4 | Viney Joanne L. | HARP | Director Stock Option (Right to Buy) | D | 22.50 | 10,167 | 10,167 | |||||
| 2021-05-07 | 2021-05-04 | 4 | BAILES JOSEPH S | HARP | Director Stock Option (Right to Buy) | D | 22.50 | 10,167 | 10,167 | |||||
| 2021-05-07 | 2021-05-04 | 4 | Myers Scott Dunseth | HARP | Director Stock Option (Right to Buy) | D | 22.50 | 10,167 | 10,167 | |||||
| 2021-05-07 | 2021-05-04 | 4 | Robbins Andrew R | HARP | Director Stock Option (Right to Buy) | D | 22.50 | 10,167 | 10,167 | |||||
| 2021-05-07 | 2021-05-04 | 4 | EASTLAND JULIA MARIE | HARP | Director Stock Option (Right to Buy) | D | 22.50 | 10,167 | 10,167 | |||||
| 2021-05-07 | 2021-05-04 | 4 | HUNT RONALD | HARP | Director Stock Option (Right to Buy) | D | 22.50 | 4,807 | 4,807 | |||||
| 2021-05-07 | 2021-05-04 | 4 | HUNT RONALD | HARP | Director Stock Option (Right to Buy) | D | 22.50 | 10,167 | 10,167 | |||||
| 2021-05-07 | 2021-05-04 | 4 | DRACHMAN JONATHAN G | HARP | Director Stock Option (Right to Buy) | D | 22.50 | 10,167 | 10,167 | |||||
| 2021-05-07 | 2021-05-04 | 4 | Chin Mark | HARP | Director Stock Option (Right to Buy) | D | 22.50 | 3,017 | 3,017 | |||||
| 2021-05-07 | 2021-05-04 | 4 | Chin Mark | HARP | Director Stock Option (Right to Buy) | D | 22.50 | 10,167 | 10,167 | |||||
| 2021-05-06 | 2021-05-05 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 23.0900 | -59 | -1 | 6,551,286 | ||||
| 2021-05-06 | 2021-05-05 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 22.5200 | -10,113 | -228 | 6,551,345 | ||||
| 2021-05-04 | 2021-05-04 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 23.3300 | -3,500 | -82 | 6,561,458 | ||||
| 2021-05-04 | 2021-05-04 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 23.0300 | -26,230 | -604 | 6,564,958 | ||||
| 2021-05-04 | 2021-05-03 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 23.4500 | -4,401 | -103 | 6,591,188 | ||||
| 2021-05-04 | 2021-05-03 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 23.0300 | -26,365 | -607 | 6,595,589 | ||||
| 2021-05-04 | 2021-04-30 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 22.3500 | -268,023 | -5,990 | 6,621,954 | ||||
| 2021-04-29 | 2021-04-29 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 22.5400 | -21,781 | -491 | 6,889,977 | ||||
| 2021-04-29 | 2021-04-29 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 22.0200 | -45,511 | -1,002 | 6,911,758 | ||||
| 2021-04-29 | 2021-04-28 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 22.0100 | -36,803 | -810 | 6,957,269 | ||||
| 2021-04-29 | 2021-04-28 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 21.6400 | -14,219 | -308 | 6,994,072 | ||||
| 2021-04-29 | 2021-04-27 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 21.2600 | -8,328 | -177 | 7,008,291 | ||||
| 2021-04-29 | 2021-04-27 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20.9900 | -3,501 | -73 | 7,016,619 | ||||
| 2021-04-22 | 2021-04-21 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 19.4800 | -555 | -11 | 7,020,120 | ||||
| 2021-04-22 | 2021-04-21 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 18.9400 | -8,417 | -159 | 7,020,675 | ||||
| 2021-04-20 | 2021-04-20 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 19.0900 | -834 | -16 | 7,029,092 | ||||
| 2021-04-20 | 2021-04-20 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 18.7000 | -21,415 | -400 | 7,029,926 | ||||
| 2021-04-20 | 2021-04-19 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20.0800 | -100 | -2 | 7,051,341 | ||||
| 2021-04-20 | 2021-04-19 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 19.2900 | -9,956 | -192 | 7,051,441 | ||||
| 2021-04-20 | 2021-04-16 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20.5600 | -300 | -6 | 7,061,397 | ||||
| 2021-04-20 | 2021-04-16 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 19.8200 | -5,547 | -110 | 7,061,697 | ||||
| 2021-04-15 | 2021-04-15 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 20.4900 | -1,052 | -22 | 3,220,844 | ||||
| 2021-04-15 | 2021-04-14 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 20.8300 | -1,550 | -32 | 3,221,896 | ||||
| 2021-04-15 | 2021-04-14 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 20.0600 | -121 | -2 | 3,223,446 | ||||
| 2021-04-15 | 2021-04-13 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 20.0800 | -286 | -6 | 3,223,567 | ||||
| 2021-04-15 | 2021-04-13 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 19.3500 | -1,657 | -32 | 3,223,853 | ||||
| 2021-04-15 | 2021-04-15 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20.4900 | -8,696 | -178 | 7,067,244 | ||||
| 2021-04-15 | 2021-04-14 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20.8300 | -12,806 | -267 | 7,075,940 | ||||
| 2021-04-15 | 2021-04-14 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20.0600 | -1,000 | -20 | 7,088,746 | ||||
| 2021-04-15 | 2021-04-13 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20.0800 | -2,362 | -47 | 7,089,746 | ||||
| 2021-04-15 | 2021-04-13 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 19.3500 | -13,692 | -265 | 7,092,108 | ||||
| 2021-04-13 | 2021-04-12 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 22.6800 | -400 | -9 | 7,105,800 | ||||
| 2021-04-13 | 2021-04-12 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 21.5200 | -6,700 | -144 | 7,106,200 | ||||
| 2021-04-13 | 2021-04-12 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20.7200 | -13,528 | -280 | 7,112,900 | ||||
| 2021-04-13 | 2021-04-09 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 23.6700 | -10,300 | -244 | 7,126,428 | ||||
| 2021-04-13 | 2021-04-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 22.6800 | -48 | -1 | 3,225,510 | ||||
| 2021-04-13 | 2021-04-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 21.5200 | -811 | -17 | 3,225,558 | ||||
| 2021-04-13 | 2021-04-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 20.7200 | -1,637 | -34 | 3,226,369 | ||||
| 2021-04-13 | 2021-04-09 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 23.6700 | -10,300 | -244 | 3,228,006 | ||||
| 2021-04-05 | 2021-04-01 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 0.60 | -1,534 | 31,002 | |||||
| 2021-04-05 | 2021-04-01 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 0.60 | -8,466 | 2,540 | |||||
| 2021-04-05 | 2021-04-01 | 4 | Wesche Holger | HARP | Common Stock | D | 21.1400 | -500 | -11 | 52,852 | ||||
| 2021-04-05 | 2021-04-01 | 4 | Wesche Holger | HARP | Common Stock | D | 20.4127 | -9,500 | -194 | 53,352 | ||||
| 2021-04-05 | 2021-04-01 | 4 | Wesche Holger | HARP | Common Stock | D | 0.6000 | 1,534 | 1 | 62,852 | ||||
| 2021-04-05 | 2021-04-01 | 4 | Wesche Holger | HARP | Common Stock | D | 0.6000 | 8,466 | 5 | 61,318 | ||||
| 2021-03-26 | 2021-03-24 | 4 | Colowick Alan | HARP | Director Stock Option (right to buy) | D | 19.63 | 20,335 | 20,335 | |||||
| 2021-02-18 | 2021-02-17 | 4 | Erbez Georgia | HARP | Employee Stock Option (right to buy) | D | 2.12 | -25,000 | 145,908 | |||||
| 2021-02-18 | 2021-02-17 | 4 | Erbez Georgia | HARP | Common Stock | D | 2.1200 | 25,000 | 53 | 72,292 | ||||
| 2021-02-12 | 2021-02-10 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 20.0000 | -183,051 | -3,661 | 3,238,306 | ||||
| 2021-02-09 | 2021-02-09 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 20.2500 | -9,400 | -190 | 3,421,357 | ||||
| 2021-02-09 | 2021-02-08 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 20.0400 | -72,128 | -1,445 | 3,430,757 | ||||
| 2021-02-09 | 2021-02-05 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 20.0100 | -10,172 | -204 | 3,502,885 | ||||
| 2021-02-04 | 2021-02-04 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 20.3700 | -29,730 | -606 | 3,513,057 | ||||
| 2021-02-04 | 2021-02-03 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 20.2100 | -41,922 | -847 | 3,542,787 | ||||
| 2021-02-04 | 2021-02-02 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 20.1300 | -48,421 | -975 | 3,584,709 | ||||
| 2021-01-29 | 2021-01-28 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 18.66 | 52,000 | 52,000 | |||||
| 2021-01-29 | 2021-01-28 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 18.66 | 80,000 | 80,000 | |||||
| 2021-01-29 | 2021-01-28 | 4 | Erbez Georgia | HARP | Employee Stock Option (right to buy) | D | 18.66 | 72,000 | 72,000 | |||||
| 2021-01-29 | 2021-01-28 | 4 | McMahon Gerald PhD | HARP | Employee Stock Option (right to buy) | D | 18.66 | 181,470 | 181,470 | |||||
| 2021-01-27 | 2021-01-27 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 20.0000 | -706,825 | -14,136 | 3,633,130 | ||||
| 2021-01-27 | 2021-01-26 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 21.0800 | -1,363 | -29 | 4,339,955 | ||||
| 2021-01-27 | 2021-01-25 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 21.2300 | -13,006 | -276 | 4,341,318 | ||||
| 2021-01-22 | 2021-01-22 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 21.7200 | -24,695 | -536 | 4,354,324 | ||||
| 2021-01-22 | 2021-01-21 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 23.7700 | -200 | -5 | 4,379,019 | ||||
| 2021-01-22 | 2021-01-21 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 22.6100 | -4,887 | -110 | 4,379,219 | ||||
| 2021-01-22 | 2021-01-21 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 22.1100 | -20,979 | -464 | 4,384,106 | ||||
| 2021-01-22 | 2021-01-20 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | -101,646 | 4,405,085 | ||||||
| 2021-01-22 | 2021-01-20 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 24.7100 | -2,000 | -49 | 4,506,731 | ||||
| 2021-01-22 | 2021-01-20 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 23.9500 | -15,694 | -376 | 4,508,731 | ||||
| 2021-01-06 | 2021-01-04 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 0.60 | -10,000 | 11,006 | |||||
| 2021-01-06 | 2021-01-04 | 4 | Wesche Holger | HARP | Common Stock | D | 19.3935 | -3,549 | -69 | 52,852 | ||||
| 2021-01-06 | 2021-01-04 | 4 | Wesche Holger | HARP | Common Stock | D | 18.3010 | -3,351 | -61 | 56,401 | ||||
| 2021-01-06 | 2021-01-04 | 4 | Wesche Holger | HARP | Common Stock | D | 17.3170 | -3,100 | -54 | 59,752 | ||||
| 2021-01-06 | 2021-01-04 | 4 | Wesche Holger | HARP | Common Stock | D | 0.6000 | 10,000 | 6 | 62,852 | ||||
| 2020-10-05 | 2020-10-01 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 0.60 | -10,000 | 21,006 | |||||
| 2020-10-05 | 2020-10-01 | 4 | Wesche Holger | HARP | Common Stock | D | 17.0299 | -1,000 | -17 | 52,669 | ||||
| 2020-10-05 | 2020-10-01 | 4 | Wesche Holger | HARP | Common Stock | D | 16.1897 | -9,000 | -146 | 53,669 | ||||
| 2020-10-05 | 2020-10-01 | 4 | Wesche Holger | HARP | Common Stock | D | 0.6000 | 10,000 | 6 | 62,669 | ||||
| 2020-08-20 | 2020-08-19 | 4 | Erbez Georgia | HARP | Common Stock | I | 11.4000 | 5,000 | 57 | 8,915 | ||||
| 2020-08-20 | 2020-08-18 | 4 | Erbez Georgia | HARP | Common Stock | I | 11.6000 | 2,098 | 24 | 3,915 | ||||
| 2020-08-04 | 2020-07-31 | 4 | Erbez Georgia | HARP | Common Stock | I | 10.9200 | 1,817 | 20 | 1,817 | ||||
| 2020-07-02 | 2020-07-01 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 0.60 | -10,000 | 31,006 | |||||
| 2020-07-02 | 2020-07-01 | 4 | Wesche Holger | HARP | Common Stock | D | 16.1989 | -10,000 | -162 | 52,669 | ||||
| 2020-07-02 | 2020-07-01 | 4 | Wesche Holger | HARP | Common Stock | D | 0.6000 | 10,000 | 6 | 62,669 | ||||
| 2020-07-02 | 2020-07-01 | 4 | Viney Joanne L. | HARP | Director Stock Option (right to buy) | D | 17.49 | 20,335 | 20,335 | |||||
| 2020-06-01 | 2020-05-28 | 4 | EASTLAND JULIA MARIE | HARP | Director Stock Option (Right to Buy) | D | 20.59 | 10,167 | 10,167 | |||||
| 2020-06-01 | 2020-05-28 | 4 | Myers Scott Dunseth | HARP | Director Stock Option (Right to Buy) | D | 20.59 | 10,167 | 10,167 | |||||
| 2020-06-01 | 2020-05-28 | 4 | DRACHMAN JONATHAN G | HARP | Director Stock Option (Right to Buy) | D | 20.59 | 2,880 | 2,880 | |||||
| 2020-06-01 | 2020-05-28 | 4 | DRACHMAN JONATHAN G | HARP | Director Stock Option (Right to Buy) | D | 20.59 | 10,167 | 10,167 | |||||
| 2020-06-01 | 2020-05-28 | 4 | HUNT RONALD | HARP | Director Stock Option (Right to Buy) | D | 20.59 | 4,906 | 4,906 | |||||
| 2020-06-01 | 2020-05-28 | 4 | HUNT RONALD | HARP | Director Stock Option (Right to Buy) | D | 20.59 | 10,167 | 10,167 | |||||
| 2020-06-01 | 2020-05-28 | 4 | EVNIN LUKE | HARP | Director Stock Option (Right to Buy) | D | 20.59 | 3,587 | 3,587 | |||||
| 2020-06-01 | 2020-05-28 | 4 | EVNIN LUKE | HARP | Director Stock Option (Right to Buy) | D | 20.59 | 10,167 | 10,167 | |||||
| 2020-06-01 | 2020-05-28 | 4 | Baeuerle Patrick | HARP | Director Stock Option (Right to Buy) | D | 20.59 | 2,584 | 2,584 | |||||
| 2020-06-01 | 2020-05-28 | 4 | Baeuerle Patrick | HARP | Director Stock Option (Right to Buy) | D | 20.59 | 10,167 | 10,167 | |||||
| 2020-06-01 | 2020-05-28 | 4 | Chin Mark | HARP | Director Stock Option (Right to Buy) | D | 20.59 | 3,017 | 3,017 | |||||
| 2020-06-01 | 2020-05-28 | 4 | Chin Mark | HARP | Director Stock Option (Right to Buy) | D | 20.59 | 10,167 | 10,167 | |||||
| 2020-05-29 | 2020-05-28 | 4 | Arix Bioscience plc | HARP | Common stock | I | 21.3342 | -366,591 | -7,821 | 2,193,704 | ||||
| 2020-05-29 | 2020-05-27 | 4 | Arix Bioscience plc | HARP | Common stock | I | 22.3926 | -12,064 | -270 | 2,560,295 | ||||
| 2020-05-20 | 2020-05-18 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2.12 | -1,522 | 45,625 | |||||
| 2020-05-20 | 2020-05-18 | 4 | Sacks Natalie | HARP | Common Stock | D | 14.7691 | -1,522 | -22 | 45,754 | ||||
| 2020-05-20 | 2020-05-18 | 4 | Sacks Natalie | HARP | Common Stock | D | 2.1200 | 1,522 | 3 | 47,276 | ||||
| 2020-05-13 | 2020-05-12 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 0.60 | -1,400 | 41,006 | |||||
| 2020-05-13 | 2020-05-12 | 4 | Wesche Holger | HARP | Common Stock | D | 14.0857 | -1,400 | -20 | 52,669 | ||||
| 2020-05-13 | 2020-05-12 | 4 | Wesche Holger | HARP | Common Stock | D | 0.6000 | 1,400 | 1 | 54,069 | ||||
| 2020-05-11 | 2020-05-11 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 0.60 | -1,000 | 42,406 | |||||
| 2020-05-11 | 2020-05-11 | 4 | Wesche Holger | HARP | Common Stock | D | 14.0651 | -1,000 | -14 | 52,669 | ||||
| 2020-05-11 | 2020-05-11 | 4 | Wesche Holger | HARP | Common Stock | D | 0.6000 | 1,000 | 1 | 53,669 | ||||
| 2020-05-11 | 2020-05-08 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 0.60 | -1,000 | 43,406 | |||||
| 2020-05-11 | 2020-05-08 | 4 | Wesche Holger | HARP | Common Stock | D | 14.0000 | -1,000 | -14 | 52,669 | ||||
| 2020-05-11 | 2020-05-08 | 4 | Wesche Holger | HARP | Common Stock | D | 0.6000 | 1,000 | 1 | 53,669 | ||||
| 2020-05-11 | 2020-05-07 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 0.60 | -5,350 | 44,406 | |||||
| 2020-05-11 | 2020-05-07 | 4 | Wesche Holger | HARP | Common Stock | D | 14.1263 | -5,350 | -76 | 52,669 | ||||
| 2020-05-11 | 2020-05-07 | 4 | Wesche Holger | HARP | Common Stock | D | 0.6000 | 5,350 | 3 | 58,019 | ||||
| 2020-05-05 | 2020-05-01 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2.12 | -5,826 | 168,926 | |||||
| 2020-05-05 | 2020-05-01 | 4 | Sacks Natalie | HARP | Common Stock | D | 12.0668 | -5,826 | -70 | 45,754 | ||||
| 2020-05-05 | 2020-05-01 | 4 | Sacks Natalie | HARP | Common Stock | D | 2.1200 | 5,826 | 12 | 51,580 | ||||
| 2020-04-30 | 2020-04-28 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 0.60 | -1,250 | 49,756 | |||||
| 2020-04-30 | 2020-04-28 | 4 | Wesche Holger | HARP | Common Stock | D | 14.0520 | -1,250 | -18 | 52,669 | ||||
| 2020-04-30 | 2020-04-28 | 4 | Wesche Holger | HARP | Common Stock | D | 0.6000 | 1,250 | 1 | 53,919 | ||||
| 2020-04-17 | 2020-04-17 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2.12 | -1,021 | 47,147 | |||||
| 2020-04-17 | 2020-04-17 | 4 | Sacks Natalie | HARP | Common Stock | D | 12.0765 | -1,021 | -12 | 45,754 | ||||
| 2020-04-17 | 2020-04-17 | 4 | Sacks Natalie | HARP | Common Stock | D | 2.1200 | 1,021 | 2 | 46,775 | ||||
| 2020-04-17 | 2020-04-16 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2.12 | -500 | 48,168 | |||||
| 2020-04-17 | 2020-04-16 | 4 | Sacks Natalie | HARP | Common Stock | D | 12.0000 | -500 | -6 | 45,754 | ||||
| 2020-04-17 | 2020-04-16 | 4 | Sacks Natalie | HARP | Common Stock | D | 2.1200 | 500 | 1 | 46,254 | ||||
| 2020-04-15 | 2020-04-13 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2.12 | -4,556 | 174,752 | |||||
| 2020-04-15 | 2020-04-13 | 4 | Sacks Natalie | HARP | Common Stock | D | 12.0630 | -4,556 | -55 | 45,754 | ||||
| 2020-04-15 | 2020-04-13 | 4 | Sacks Natalie | HARP | Common Stock | D | 2.1200 | 4,556 | 10 | 50,310 | ||||
| 2020-04-08 | 2020-04-07 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2.12 | -570 | 179,308 | |||||
| 2020-04-08 | 2020-04-07 | 4 | Sacks Natalie | HARP | Common Stock | D | 12.0000 | -570 | -7 | 45,754 | ||||
| 2020-04-08 | 2020-04-07 | 4 | Sacks Natalie | HARP | Common Stock | D | 2.1200 | 570 | 1 | 46,324 | ||||
| 2020-04-08 | 2020-04-06 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2.12 | -700 | 179,878 | |||||
| 2020-04-08 | 2020-04-06 | 4 | Sacks Natalie | HARP | Common Stock | D | 12.0014 | -700 | -8 | 45,754 | ||||
| 2020-04-08 | 2020-04-06 | 4 | Sacks Natalie | HARP | Common Stock | D | 2.1200 | 700 | 1 | 46,454 | ||||
| 2020-04-01 | 2020-03-30 | 4 | Robbins Andrew R | HARP | Director Stock Option (right to buy) | D | 11.78 | 20,335 | 20,335 | |||||
| 2020-04-01 | 2020-03-30 | 4 | BAILES JOSEPH S | HARP | Director Stock Option (right to buy) | D | 11.78 | 20,335 | 20,335 | |||||
| 2020-03-18 | 2020-03-17 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2.12 | -1,520 | 48,668 | |||||
| 2020-03-18 | 2020-03-17 | 4 | Sacks Natalie | HARP | Common Stock | D | 12.0000 | -1,520 | -18 | 45,754 | ||||
| 2020-03-18 | 2020-03-17 | 4 | Sacks Natalie | HARP | Common Stock | D | 2.1200 | 1,520 | 3 | 47,274 | ||||
| 2020-03-18 | 2020-03-16 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2.12 | -1 | 50,188 | |||||
| 2020-03-18 | 2020-03-16 | 4 | Sacks Natalie | HARP | Common Stock | D | 12.0000 | -1 | -0 | 45,754 | ||||
| 2020-03-18 | 2020-03-16 | 4 | Sacks Natalie | HARP | Common Stock | D | 2.1200 | 1 | 0 | 45,755 | ||||
| 2020-03-03 | 2020-03-02 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2.12 | -5,826 | 180,578 | |||||
| 2020-03-03 | 2020-03-02 | 4 | Sacks Natalie | HARP | Common Stock | D | 14.6800 | -5,826 | -86 | 45,754 | ||||
| 2020-03-03 | 2020-03-02 | 4 | Sacks Natalie | HARP | Common Stock | D | 2.1200 | 5,826 | 12 | 51,580 | ||||
| 2020-02-20 | 2020-02-18 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2.12 | -1,521 | 50,189 | |||||
| 2020-02-20 | 2020-02-18 | 4 | Sacks Natalie | HARP | Common Stock | D | 15.0000 | -1,521 | -23 | 45,754 | ||||
| 2020-02-20 | 2020-02-18 | 4 | Sacks Natalie | HARP | Common Stock | D | 2.1200 | 1,521 | 3 | 47,275 | ||||
| 2020-02-04 | 2020-01-31 | 4 | McMahon Gerald PhD | HARP | Employee Stock Option (right to buy) | D | 13.29 | 165,210 | 165,210 | |||||
| 2020-02-04 | 2020-01-31 | 4 | Erbez Georgia | HARP | Employee Stock Option (right to buy) | D | 13.29 | 52,160 | 52,160 | |||||
| 2020-02-04 | 2020-02-03 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2.12 | -5,826 | 186,404 | |||||
| 2020-02-04 | 2020-02-03 | 4 | Sacks Natalie | HARP | Common Stock | D | 13.9043 | -5,826 | -81 | 45,754 | ||||
| 2020-02-04 | 2020-02-03 | 4 | Sacks Natalie | HARP | Common Stock | D | 2.1200 | 5,826 | 12 | 51,580 | ||||
| 2020-02-04 | 2020-01-31 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 13.29 | 75,440 | 75,440 | |||||
| 2020-02-04 | 2020-01-31 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 13.29 | 52,313 | 52,313 | |||||
| 2020-01-23 | 2020-01-21 | 4 | Erbez Georgia | HARP | Common Stock | I | 14.0922 | 6,700 | 94 | 6,700 | ||||
| 2020-01-21 | 2020-01-16 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2.12 | -1,521 | 51,710 | |||||
| 2020-01-21 | 2020-01-16 | 4 | Sacks Natalie | HARP | Common Stock | D | 14.9408 | -1,521 | -23 | 45,754 | ||||
| 2020-01-21 | 2020-01-16 | 4 | Sacks Natalie | HARP | Common Stock | D | 2.1200 | 1,521 | 3 | 47,275 | ||||
| 2020-01-06 | 2020-01-02 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 0.60 | -10,000 | 51,006 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Wesche Holger | HARP | Common Stock | D | 14.3987 | -10,000 | -144 | 52,669 | ||||
| 2020-01-06 | 2020-01-02 | 4 | Wesche Holger | HARP | Common Stock | D | 0.6000 | 10,000 | 6 | 62,669 | ||||
| 2020-01-06 | 2020-01-02 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2.12 | -5,826 | 192,230 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Sacks Natalie | HARP | Common Stock | D | 14.1779 | -5,826 | -83 | 45,754 | ||||
| 2020-01-06 | 2020-01-02 | 4 | Sacks Natalie | HARP | Common Stock | D | 2.1200 | 5,826 | 12 | 51,580 | ||||
| 2019-12-30 | 2019-12-27 | 4 | Baeuerle Patrick | HARP | Common Stock | I | 18.0690 | -1,400 | -25 | 262,136 | ||||
| 2019-12-30 | 2019-12-27 | 4 | Baeuerle Patrick | HARP | Common Stock | I | 16.9014 | -10,417 | -176 | 263,536 | ||||
| 2019-12-30 | 2019-12-27 | 4 | Baeuerle Patrick | HARP | Common Stock | I | 15.8138 | -75,562 | -1,195 | 273,953 | ||||
| 2019-12-18 | 2019-12-16 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2.12 | -1,521 | 53,231 | |||||
| 2019-12-18 | 2019-12-16 | 4 | Sacks Natalie | HARP | Common Stock | D | 17.0201 | -1,521 | -26 | 45,754 | ||||
| 2019-12-18 | 2019-12-16 | 4 | Sacks Natalie | HARP | Common Stock | D | 2.1200 | 1,521 | 3 | 47,275 | ||||
| 2019-12-17 | 2019-12-17 | 4 | Chin Mark By Arix Bioscience Holdings Limited | HARP | Common Stock | I | 16.8298 | -12,476 | -210 | 2,572,359 | ||||
| 2019-12-17 | 2019-12-16 | 4 | Chin Mark By Arix Bioscience Holdings Limited | HARP | Common Stock | I | 17.0245 | -13,080 | -223 | 2,584,835 | ||||
| 2019-12-17 | 2019-12-13 | 4 | Chin Mark By Arix Bioscience Holdings Limited | HARP | Common Stock | I | 17.2097 | -11,002 | -189 | 2,597,915 | ||||
| 2019-12-17 | 2019-12-17 | 4 | Arix Bioscience plc | HARP | Common stock | I | 16.8298 | -12,476 | -210 | 2,572,359 | ||||
| 2019-12-17 | 2019-12-16 | 4 | Arix Bioscience plc | HARP | Common stock | I | 17.0245 | -13,080 | -223 | 2,584,835 | ||||
| 2019-12-17 | 2019-12-13 | 4 | Arix Bioscience plc | HARP | Common stock | I | 17.2097 | -11,002 | -189 | 2,597,915 | ||||
| 2019-12-10 | 2019-12-10 | 4 | Chin Mark By Arix Bioscience Holdings Limited | HARP | Common Stock | I | 16.9103 | -131,696 | -2,227 | 2,608,917 | ||||
| 2019-12-10 | 2019-12-09 | 4 | Chin Mark By Arix Bioscience Holdings Limited | HARP | Common Stock | I | 18.1161 | -77,316 | -1,401 | 2,740,613 | ||||
| 2019-12-10 | 2019-12-09 | 4 | Chin Mark By Arix Bioscience Holdings Limited | HARP | Common Stock | I | 18.2987 | -26,438 | -484 | 2,817,929 | ||||
| 2019-12-10 | 2019-12-06 | 4 | Chin Mark By Arix Bioscience Holdings Limited | HARP | Common Stock | I | 19.1452 | -47,752 | -914 | 2,844,367 | ||||
| 2019-12-10 | 2019-12-10 | 4 | Arix Bioscience plc | HARP | Common stock | I | 16.9103 | -131,696 | -2,227 | 2,608,917 | ||||
| 2019-12-10 | 2019-12-09 | 4 | Arix Bioscience plc | HARP | Common stock | I | 18.1161 | -77,316 | -1,401 | 2,740,613 | ||||
| 2019-12-10 | 2019-12-09 | 4 | Arix Bioscience plc | HARP | Common stock | I | 18.2987 | -26,438 | -484 | 2,817,929 | ||||
| 2019-12-10 | 2019-12-06 | 4 | Arix Bioscience plc | HARP | Common stock | I | 19.1452 | -47,752 | -914 | 2,844,367 | ||||
| 2019-12-06 | 2019-12-04 | 4 | Erbez Georgia | HARP | Employee Stock Option (right to buy) | D | 2.12 | -47,292 | 170,908 | |||||
| 2019-12-06 | 2019-12-04 | 4 | Erbez Georgia | HARP | Common Stock | D | 2.1200 | 47,292 | 100 | 47,292 | ||||
| 2019-12-04 | 2019-12-02 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2.12 | -5,826 | 198,056 | |||||
| 2019-12-04 | 2019-12-02 | 4 | Sacks Natalie | HARP | Common Stock | D | 17.9800 | -5,826 | -105 | 45,754 | ||||
| 2019-12-04 | 2019-12-02 | 4 | Sacks Natalie | HARP | Common Stock | D | 2.1200 | 5,826 | 12 | 51,580 | ||||
| 2019-11-19 | 2019-11-18 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2.12 | -18,252 | 54,752 | |||||
| 2019-11-19 | 2019-11-18 | 4 | Sacks Natalie | HARP | Common Stock | D | 14.0000 | -1,000 | -14 | 45,754 | ||||
| 2019-11-19 | 2019-11-18 | 4 | Sacks Natalie | HARP | Common Stock | D | 13.3297 | -17,252 | -230 | 46,754 | ||||
| 2019-11-19 | 2019-11-18 | 4 | Sacks Natalie | HARP | Common Stock | D | 2.1200 | 18,252 | 39 | 64,006 | ||||
| 2019-11-05 | 2019-11-01 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2.12 | -5,826 | 203,882 | |||||
| 2019-11-05 | 2019-11-01 | 4 | Sacks Natalie | HARP | Common Stock | D | 13.1654 | -5,826 | -77 | 45,754 | ||||
| 2019-11-05 | 2019-11-01 | 4 | Sacks Natalie | HARP | Common Stock | D | 2.1200 | 5,826 | 12 | 51,580 | ||||
| 2019-10-16 | 2019-10-15 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2.12 | -11,698 | 209,708 | |||||
| 2019-10-16 | 2019-10-15 | 4 | Sacks Natalie | HARP | Common Stock | D | 13.2058 | -11,698 | -154 | 45,754 | ||||
| 2019-10-16 | 2019-10-15 | 4 | Sacks Natalie | HARP | Common Stock | D | 2.1200 | 11,698 | 25 | 57,452 | ||||
| 2019-10-16 | 2019-10-14 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2.12 | -12,452 | 221,406 | |||||
| 2019-10-16 | 2019-10-14 | 4 | Sacks Natalie | HARP | Common Stock | D | 13.2734 | -12,452 | -165 | 45,754 | ||||
| 2019-10-16 | 2019-10-14 | 4 | Sacks Natalie | HARP | Common Stock | D | 2.1200 | 12,452 | 26 | 58,206 | ||||
| 2019-09-06 | 2019-06-05 | 4 | McMahon Gerald PhD | HARP | Employee Stock Option (right to buy) | D | 0.60 | -169,462 | 318,590 | |||||
| 2019-09-06 | 2019-06-05 | 4 | McMahon Gerald PhD | HARP | Common Stock | D | 0.6000 | 169,462 | 102 | 172,462 | ||||
| 2019-06-05 | 2019-06-03 | 4 | DRACHMAN JONATHAN G | HARP | Director Stock Option (Right to Buy) | D | 11.84 | 10,167 | 10,167 | |||||
| 2019-06-05 | 2019-06-03 | 4 | EASTLAND JULIA MARIE | HARP | Director Stock Option (Right to Buy) | D | 11.84 | 10,167 | 10,167 | |||||
| 2019-06-05 | 2019-06-03 | 4 | EVNIN LUKE | HARP | Director Stock Option (Right to Buy) | D | 11.84 | 10,167 | 10,167 | |||||
| 2019-06-05 | 2019-06-03 | 4 | HUNT RONALD | HARP | Director Stock Option (Right to Buy) | D | 11.84 | 10,167 | 10,167 | |||||
| 2019-06-05 | 2019-06-03 | 4 | Myers Scott Dunseth | HARP | Director Stock Option (Right to Buy) | D | 11.84 | 10,167 | 10,167 | |||||
| 2019-06-05 | 2019-06-03 | 4 | Baeuerle Patrick | HARP | Director Stock Option (Right to Buy) | D | 11.84 | 10,167 | 10,167 | |||||
| 2019-06-05 | 2019-06-03 | 4 | Chin Mark | HARP | Director Stock Option (Right to Buy) | D | 11.84 | 10,167 | 10,167 | |||||
| 2019-05-16 | 2019-05-14 | 4 | McMahon Gerald PhD | HARP | Common Stock | D | 10.1573 | 1,000 | 10 | 3,000 | ||||
| 2019-05-10 | 2019-05-08 | 4 | McMahon Gerald PhD | HARP | Common Stock | D | 10.5587 | 1,000 | 11 | 2,000 | ||||
| 2019-05-07 | 2019-05-03 | 4 | McMahon Gerald PhD | HARP | Common Stock | D | 10.5300 | 1,000 | 11 | 1,000 | ||||
| 2019-03-29 | 2019-02-07 | 4/A | Chin Mark | HARP | Director Stock Option (Right to Buy) | D | 14.00 | 6,071 | 6,071 | |||||
| 2019-03-29 | 2019-02-07 | 4/A | EVNIN LUKE | HARP | Director Stock Option (Right to Buy) | D | 14.00 | 7,658 | 7,658 | |||||
| 2019-03-29 | 2019-02-07 | 4/A | HUNT RONALD | HARP | Director Stock Option (Right to Buy) | D | 14.00 | 4,923 | 4,923 | |||||
| 2019-03-29 | 2019-02-07 | 4 | DRACHMAN JONATHAN G | HARP | Director Stock Option (Right to Buy) | D | 14.00 | 4,266 | 4,266 | |||||
| 2019-03-29 | 2019-02-07 | 4 | EASTLAND JULIA MARIE | HARP | Director Stock Option (Right to Buy) | D | 14.00 | 5,907 | 5,907 | |||||
| 2019-03-29 | 2019-02-07 | 4 | Baeuerle Patrick | HARP | Director Stock Option (Right to Buy) | D | 14.00 | 3,829 | 3,829 | |||||
| 2019-02-14 | 2019-02-12 | 4 | Arix Bioscience plc | HARP | Series C Convertible Preferred Stock | I | -742,850 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | Arix Bioscience plc | HARP | Series B Convertible Preferred Stock | I | -1,720,698 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | Arix Bioscience plc | HARP | Common stock | I | 14.0000 | 428,571 | 6,000 | 2,892,119 | ||||
| 2019-02-14 | 2019-02-12 | 4 | Arix Bioscience plc | HARP | Common stock | I | 2,463,548 | 2,463,548 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Common Stock Warrant (Right to Buy) | I | 0.05 | -50,837 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Common Stock Warrant (Right to Buy) | I | 0.05 | -50,837 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Common Stock Warrant (Right to Buy) | I | 0.05 | -76,256 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Common Stock Warrant (Right to Buy) | I | 0.05 | -171,579 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Common Stock Warrant (Right to Buy) | I | 0.05 | -57,192 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Common Stock Warrant (Right to Buy) | I | 0.05 | -25,418 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Series C Preferred Stock | I | -417,852 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Series B Preferred Stock | I | -1,578,751 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Series A Preferred Stock | I | -1,525,164 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Common Stock | I | 14.0000 | 250,000 | 3,500 | 4,524,425 | ||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Common Stock | I | 14.0000 | -1,524 | -21 | 4,274,425 | ||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Common Stock | I | 0.0492 | 432,119 | 21 | 4,275,949 | ||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Common Stock | I | 417,852 | 3,843,830 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Common Stock | I | 1,578,751 | 3,425,978 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Common Stock | I | 1,525,164 | 1,847,227 | ||||||
| 2019-02-14 | 2018-12-19 | 4 | EVNIN LUKE | HARP | Director Stock Option (Right to Buy) | D | 2.12 | 20,335 | 20,335 | |||||
| 2019-02-14 | 2018-11-09 | 4 | EVNIN LUKE | HARP | Series C Preferred Stock | I | 417,852 | 417,852 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | Chin Mark By Arix Bioscience Holdings Limited | HARP | Series C Preferred Stock | I | -742,850 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | Chin Mark By Arix Bioscience Holdings Limited | HARP | Series B Preferred Stock | I | -1,720,698 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | Chin Mark By Arix Bioscience Holdings Limited | HARP | Common Stock | I | 14.0000 | 428,571 | 6,000 | 2,892,119 | ||||
| 2019-02-14 | 2019-02-12 | 4 | Chin Mark By Arix Bioscience Holdings Limited | HARP | Common Stock | I | 742,850 | 2,463,548 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | Chin Mark By Arix Bioscience Holdings Limited | HARP | Common Stock | I | 1,720,698 | 1,720,698 | ||||||
| 2019-02-14 | 2018-12-19 | 4 | Chin Mark | HARP | Director Stock Option (Right to Buy) | D | 2.12 | 20,335 | 20,335 | |||||
| 2019-02-14 | 2018-11-09 | 4 | Chin Mark By Arix Bioscience Holdings Limited | HARP | Series C Preferred Stock | I | 742,850 | 742,850 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Common Stock Warrant (Right to Buy) | I | 0.05 | -101,675 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Common Stock Warrant (Right to Buy) | I | 0.05 | -152,514 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Common Stock Warrant (Right to Buy) | I | 0.05 | -50,837 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Common Stock Warrant (Right to Buy) | I | 0.05 | -171,579 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Common Stock Warrant (Right to Buy) | I | 0.05 | -57,192 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Common Stock Warrant (Right to Buy) | I | 0.05 | -25,418 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Series C Preferred Stock | I | -835,705 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Series B Preferred Stock | I | -3,157,506 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Series A Preferred Stock | I | -3,050,329 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 14.0000 | 500,000 | 7,000 | 8,422,847 | ||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 14.0000 | -1,971 | -28 | 7,922,847 | ||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 0.0492 | 559,215 | 28 | 7,924,818 | ||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 835,705 | 7,365,603 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 3,157,506 | 6,529,898 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 3,050,329 | 3,372,392 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | HUNT RONALD | HARP | Series C Convertible Preferred Stock | I | -464,281 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | HUNT RONALD | HARP | Series C Convertible Preferred Stock | I | -464,281 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | HUNT RONALD | HARP | Series B Convertible Preferred Stock | I | -1,564,272 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | HUNT RONALD | HARP | Common Stock | I | 14.0000 | 214,285 | 3,000 | 678,566 | ||||
| 2019-02-14 | 2019-02-12 | 4 | HUNT RONALD | HARP | Common Stock | I | 14.0000 | 214,286 | 3,000 | 2,242,839 | ||||
| 2019-02-14 | 2019-02-12 | 4 | HUNT RONALD | HARP | Common Stock | I | 464,281 | 464,281 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | HUNT RONALD | HARP | Common Stock | I | 464,281 | 464,281 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | HUNT RONALD | HARP | Common Stock | I | 1,564,272 | 1,564,272 | ||||||
| 2019-02-14 | 2018-12-19 | 4 | HUNT RONALD | HARP | Director Stock Option (right to buy) | D | 2.12 | 20,335 | 20,335 | |||||
| 2019-02-14 | 2018-11-09 | 4 | HUNT RONALD | HARP | Series C Convertible Preferred Stock | I | 464,281 | 464,281 | ||||||
| 2019-02-14 | 2018-11-09 | 4 | HUNT RONALD | HARP | Series C Convertible Preferred Stock | I | 464,281 | 464,281 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock Warrant (Right to Buy) | I | 0.05 | -50,837 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock Warrant (Right to Buy) | I | 0.05 | -50,837 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock Warrant (Right to Buy) | I | 0.05 | -76,256 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock Warrant (Right to Buy) | I | 0.05 | -171,579 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock Warrant (Right to Buy) | I | 0.05 | -57,192 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock Warrant (Right to Buy) | I | 0.05 | -25,418 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Series C Preferred Stock | I | -417,852 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Series B Preferred Stock | I | -1,578,751 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Series A Preferred Stock | I | -1,525,164 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 14.0000 | 250,000 | 3,500 | 4,524,425 | ||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 14.0000 | -1,524 | -21 | 4,274,425 | ||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 0.0492 | 432,119 | 21 | 4,275,949 | ||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 417,852 | 3,843,830 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 1,578,751 | 3,425,978 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 1,525,164 | 1,847,227 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | New Leaf Ventures III, L.P. | HARP | Series C Convertible Preferred Stock | I | -464,281 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | New Leaf Ventures III, L.P. | HARP | Series C Convertible Preferred Stock | I | -464,281 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | New Leaf Ventures III, L.P. | HARP | Series B Convertible Preferred Stock | I | -1,564,272 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | New Leaf Ventures III, L.P. | HARP | Common Stock | I | 14.0000 | 214,285 | 3,000 | 678,566 | ||||
| 2019-02-14 | 2019-02-12 | 4 | New Leaf Ventures III, L.P. | HARP | Common Stock | I | 14.0000 | 214,286 | 3,000 | 2,242,839 | ||||
| 2019-02-14 | 2019-02-12 | 4 | New Leaf Ventures III, L.P. | HARP | Common Stock | I | 464,281 | 464,281 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | New Leaf Ventures III, L.P. | HARP | Common Stock | I | 464,281 | 464,281 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | New Leaf Ventures III, L.P. | HARP | Common Stock | I | 1,564,272 | 1,564,272 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | UBS Oncology Impact Fund L.P. | HARP | Common Stock Warrant (Right to Buy) | D | 0.05 | -50,838 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | UBS Oncology Impact Fund L.P. | HARP | Common Stock Warrant (Right to Buy) | D | 0.05 | -76,258 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | UBS Oncology Impact Fund L.P. | HARP | Series C Preferred Stock | D | -417,853 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | UBS Oncology Impact Fund L.P. | HARP | Series B Preferred Stock | D | -1,578,755 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | UBS Oncology Impact Fund L.P. | HARP | Series A Preferred Stock | D | -1,525,165 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | UBS Oncology Impact Fund L.P. | HARP | Common Stock | D | 14.0000 | 250,000 | 3,500 | 3,898,422 | ||||
| 2019-02-14 | 2019-02-12 | 4 | UBS Oncology Impact Fund L.P. | HARP | Common Stock | D | 14.0000 | -447 | -6 | 3,648,422 | ||||
| 2019-02-14 | 2019-02-12 | 4 | UBS Oncology Impact Fund L.P. | HARP | Common Stock | D | 0.0492 | 127,096 | 6 | 3,648,869 | ||||
| 2019-02-14 | 2019-02-12 | 4 | UBS Oncology Impact Fund L.P. | HARP | Common Stock | D | 417,853 | 3,521,773 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | UBS Oncology Impact Fund L.P. | HARP | Common Stock | D | 1,578,755 | 3,103,920 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | UBS Oncology Impact Fund L.P. | HARP | Common Stock | D | 1,525,165 | 1,525,165 | ||||||
| 2019-02-07 | 3 | Myers Scott Dunseth | HARP | Common Stock | D | 55,312 | ||||||||
| 2019-02-07 | 3 | Myers Scott Dunseth | HARP | Common Stock | D | 55,312 | ||||||||
| 2019-02-07 | 3 | Myers Scott Dunseth | HARP | Common Stock | D | 55,312 | ||||||||
| 2019-02-07 | 3 | MPM ASSET MANAGEMENT LLC | HARP | Common Stock | I | 644,126 | ||||||||
| 2019-02-07 | 3 | MPM ASSET MANAGEMENT LLC | HARP | Common Stock | I | 644,126 | ||||||||
| 2019-02-07 | 3 | MPM ASSET MANAGEMENT LLC | HARP | Common Stock | I | 644,126 | ||||||||
| 2019-02-07 | 3 | MPM ASSET MANAGEMENT LLC | HARP | Common Stock | I | 644,126 | ||||||||
| 2019-02-07 | 3 | MPM ASSET MANAGEMENT LLC | HARP | Common Stock | I | 644,126 | ||||||||
| 2019-02-07 | 3 | MPM ASSET MANAGEMENT LLC | HARP | Common Stock | I | 644,126 | ||||||||
| 2019-02-07 | 3 | MPM ASSET MANAGEMENT LLC | HARP | Common Stock | I | 644,126 | ||||||||
| 2019-02-07 | 3 | MPM ASSET MANAGEMENT LLC | HARP | Common Stock | I | 644,126 | ||||||||
| 2019-02-07 | 3 | MPM ASSET MANAGEMENT LLC | HARP | Common Stock | I | 644,126 | ||||||||
| 2019-02-07 | 3 | GADICKE ANSBERT | HARP | Common Stock | I | 644,126 | ||||||||
| 2019-02-07 | 3 | GADICKE ANSBERT | HARP | Common Stock | I | 644,126 | ||||||||
| 2019-02-07 | 3 | GADICKE ANSBERT | HARP | Common Stock | I | 644,126 | ||||||||
| 2019-02-07 | 3 | Baeuerle Patrick | HARP | Common Stock | I | 699,030 | ||||||||
| 2019-02-07 | 3 | Baeuerle Patrick | HARP | Common Stock | I | 699,030 | ||||||||
| 2019-02-07 | 3 | Baeuerle Patrick | HARP | Common Stock | I | 699,030 | ||||||||
| 2019-02-07 | 3 | EVNIN LUKE | HARP | Common Stock | I | 644,126 | ||||||||
| 2019-02-07 | 3 | EVNIN LUKE | HARP | Common Stock | I | 644,126 | ||||||||
| 2019-02-07 | 3 | EVNIN LUKE | HARP | Common Stock | I | 644,126 | ||||||||
| 2019-02-07 | 3 | Sacks Natalie | HARP | Common Stock | D | 91,508 | ||||||||
| 2019-02-07 | 3 | Sacks Natalie | HARP | Common Stock | D | 91,508 | ||||||||
| 2019-02-07 | 3 | Sacks Natalie | HARP | Common Stock | D | 91,508 | ||||||||
| 2019-02-07 | 3 | Wesche Holger | HARP | Common Stock | D | 105,338 | ||||||||
| 2019-02-07 | 3 | Wesche Holger | HARP | Common Stock | D | 105,338 | ||||||||
| 2019-02-07 | 3 | Wesche Holger | HARP | Common Stock | D | 105,338 |
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)
